We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Large and expanding pipeline of UK opportunity to be led by two industry experts with strong experience from stints at large wireless and IT organisations Australian ASX-listed data...
Czech generic drug maker Zentiva NV (BAAZEN.PR) Friday said it will issue 986,520 new ordinary shares to cover stock options ahead of Sanofi-Aventis SA's (2057.FR) expected EUR1.8 billion takeover...
Czech generic drug maker Zentiva NV (BAAZEN.PR) Tuesday said that units of PPF Group NV and Generali PPF Holding NV have fully withdrawn their recent court petition against Zentiva. This comment...
The second-largest shareholder in Czech generic drug maker Zentiva NV (BAAZEN.PR) Monday called off its petition for an extraordinary general meeting, removing at least one hurdle in...
The second-largest shareholder in Czech generic drug maker Zentiva NV (BAAZEN.PR) Monday called off its petition for an extraordinary general meeting, seemingly removing a hurdle in Sanofi-Aventis...
The board of directors of Czech generic drug maker Zentiva NV (BAAZEN.PR) reiterated Monday at an extraordinary general meeting its support for Sanofi-Aventis SA's (2057.FR) EUR1.8 billion...
Zentiva N.V. Wednesday said it has been informed by Anthiarose Limited, a wholly owned subsidiary of PPF Group N.V., and Ceska pojistovna, a member of Generali PPF Holding N.V., that they have...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | -0.066 | -68.0412371134 | 0.097 | 0.11 | 0.031 | 257177 | 0.05775613 | DE |
260 | -0.139 | -81.7647058824 | 0.17 | 0.265 | 0.031 | 290146 | 0.1226717 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions